Table 3.

Events during induction therapy

EventPatients, n%
Fever at presentation 75 37.5 
 Presumptive site of infection   
  Lung (pneumonia) 10 5.0 
  Skin (cellulitis) 1.5 
  Bone (osteomyelitis) 0.5 
  Viral infection (hepatitis A, varicella) 1.0 
  Gastrointestinal tract (colitis, gastroenteritis) 1.5 
Fever and/or infection during induction 135 67.5 
 Presumptive site of infection   
   Lung (pneumonia) 23 11.5 
  Skin (cellulitis) 4.5 
  Central venous catheter 1.0 
  Perianal region 2.0 
  Gastrointestinal tract 4.0 
  Urinary tract 0.5 
Bacteremia   
 At presentation 11 5.5 
 During induction 50 25.0 
Fungal infection (suspected pulmonary and/or sinus) (median time, 16 days; range, 1-30) 18 9.0 
Thrombosis   
 Cerebral 1.0 
 Deep venous thrombosis 0.5 
Pancreatitis 1.5 
Hypertension 1.5 
Mucositis grade 3 2.5 
Seizures 1.0 
Bleeding (pulmonary, melena, and hematuria) 2.5 
Mortality (early deaths) 1.5 
EventPatients, n%
Fever at presentation 75 37.5 
 Presumptive site of infection   
  Lung (pneumonia) 10 5.0 
  Skin (cellulitis) 1.5 
  Bone (osteomyelitis) 0.5 
  Viral infection (hepatitis A, varicella) 1.0 
  Gastrointestinal tract (colitis, gastroenteritis) 1.5 
Fever and/or infection during induction 135 67.5 
 Presumptive site of infection   
   Lung (pneumonia) 23 11.5 
  Skin (cellulitis) 4.5 
  Central venous catheter 1.0 
  Perianal region 2.0 
  Gastrointestinal tract 4.0 
  Urinary tract 0.5 
Bacteremia   
 At presentation 11 5.5 
 During induction 50 25.0 
Fungal infection (suspected pulmonary and/or sinus) (median time, 16 days; range, 1-30) 18 9.0 
Thrombosis   
 Cerebral 1.0 
 Deep venous thrombosis 0.5 
Pancreatitis 1.5 
Hypertension 1.5 
Mucositis grade 3 2.5 
Seizures 1.0 
Bleeding (pulmonary, melena, and hematuria) 2.5 
Mortality (early deaths) 1.5 
Close Modal

or Create an Account

Close Modal
Close Modal